VEGF News and Research

RSS
VEGF is a substance made by cells that stimulates new blood vessel formation. Also called vascular endothelial growth factor.
Experimental drug may be twice as good at fighting vision loss as previously thought

Experimental drug may be twice as good at fighting vision loss as previously thought

Gene medication shows promise to treat spinal cord injuries

Gene medication shows promise to treat spinal cord injuries

Study suggests new approach to ameliorating obesity-associated metabolic abnormalities

Study suggests new approach to ameliorating obesity-associated metabolic abnormalities

Study shows therapeutic potential of VEGF-A mRNA for regenerative angiogenesis in humans

Study shows therapeutic potential of VEGF-A mRNA for regenerative angiogenesis in humans

Lab model reveals the formation of new blood vessels

Lab model reveals the formation of new blood vessels

Complex interplay of two growth factors key to fast-acting antidepressant actions

Complex interplay of two growth factors key to fast-acting antidepressant actions

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients

Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Immunotherapy medicine found to be effective in treating uveitis

Immunotherapy medicine found to be effective in treating uveitis

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix resubmits NDA for DEXTENZA